A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy. . . . → Read More: Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy
|
|||||
       |
Researchers from a university biochemistry lab and company developing synthetic enzymes designed techniques using engineered bacteria to detect buried land mines at longer distances. . . . → Read More: Biosensor Developed to Detect Explosives, Land Mines 
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease. . . . → Read More: Small Biz Grant Supports Regenerative Alzheimer’s Treatment 
Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies. . . . → Read More: Neurons from Stem Cells Produced for Overdose Therapy Tests If you’ve used CBD for these reasons above, you might enjoy peace of mind knowing scientists have found the possible benefits you’ve known all along. . . . → Read More: What Science Has to Say About CBD  One comment - (Comments are closed)  Business conditions  biomedical, chemistry, life sciences, pharmaceuticals, physical sciences, sponsored 
A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders. . . . → Read More: Trial Begins for Multi-Neurological Disease Therapy Comments are closed New products biomedical, biotechnology, chemistry, clinical trials, life sciences, pharmaceuticals, physical sciences, university 
A company developing a drug delivery process with treatments activated by ultrasound received an option to license a key technology from its founders’ university labs. . . . → Read More: Company Gains Ultrasound-Linked Drug Capsule Technology 
A new company with a process using artificial intelligence and robotics to speed development of sustained release drugs is raising $4 million in seed funds. . . . → Read More: Long-Acting Drug Start-Up Raises $4M in Seed Funds Comments are closed Finance, New products biomedical, chemistry, engineering, entrepreneurs, equity, investment, life sciences, materials science, mathematics, pharmaceuticals, physical sciences, robotics, venture capital 
A clinical trial assessing a synthetic antibody to generate an immediate response and also generate a more durable treatment for solid tumor cancers, advanced to a mid-stage study. . . . → Read More: Trial Advances of Dual-Action Cancer Immunotherapy Comments are closed New products biomedical, biotechnology, cancer, chemistry, clinical trials, Europe, Korea, life sciences, pharmaceuticals, physical sciences 
A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round. . . . → Read More: Digital Chemistry Start-Up Gains $43M in Early Funds One comment - (Comments are closed) Finance, New products biotechnology, chemistry, computer science, engineering, entrepreneurs, equity, investment, life sciences, manufacturing, materials science, mathematics, pharmaceuticals, physical sciences, robotics, software, U.K., university |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts